论文部分内容阅读
目的探讨孟鲁司特钠致不良反应的发生特点及规律,为临床合理用药提供理论依据。方法选取2012年12月至2014年12月汕头市妇幼保健院收治的孟鲁司特钠致不良反应患者23例为研究对象,分析孟鲁司特钠所致不良反应患者的年龄分布及不良发应的发生种类。结果孟鲁司特钠所致不良反应多发生于5~10岁儿童,其发生率为73.9%(17/23);10岁以上儿童的发生率为4.35%(1/23);5岁以下儿童发生率为21.7%(5/23)。23例不良反应主要包括过敏、头痛、腹泻、遗尿、膝关节疼痛、精神异常等,其中皮肤系统不良反应最多,共8例(34.8%);其次为神经系统不良反应,共6例(26.1%);泌尿系统、消化系统及骨骼系统不良反应分别有4例(17.4%)、3例(13.0%)、2例(8.7%)。结论孟鲁司特钠所致不良反应多发生于5~10岁儿童,以皮肤过敏反应和精神异常最为常见。临床应特别关注儿童用药,以确保孟鲁司特钠的安全应用。
Objective To explore the characteristics and rules of adverse reactions caused by montelukast sodium and to provide a theoretical basis for clinical rational drug use. Methods Twenty-three patients with adverse reactions of montelukast sodium admitted from Shantou MCH hospital from December 2012 to December 2014 were selected as the research object to analyze the age distribution and adverse reactions of patients with adverse reactions caused by montelukast sodium The type of occurrence Results Adverse reactions of montelukast sodium occurred mostly in children aged 5 to 10 years, with a rate of 73.9% (17/23) and children over 10 years old with a rate of 4.35% (1/23) The incidence of children was 21.7% (5/23). There were 8 cases (34.8%) of the adverse reaction in the skin system, followed by the adverse reaction of the nervous system, 6 cases (26.1%) had adverse reactions, including allergy, headache, diarrhea, enuresis, knee pain and mental disorders. ) Urinary system, digestive system and skeletal system adverse reactions were 4 cases (17.4%), 3 cases (13.0%), 2 cases (8.7%). Conclusion The adverse reaction caused by montelukast sodium occurred mostly in children aged 5 to 10 years. Skin allergic reactions and mental disorders were the most common. Clinical special attention should be given to children’s medication to ensure the safe use of montelukast sodium.